Search Login Register

Ganglioglioma Summary

Description: Rare indolent tumors comprised of neoplastic glial and neuronal cells which occur primarily in children and young adults. Benign lesions tend to be associated with long survival unless the tumor degenerates into a histologically malignant form. They tend to occur in the optic nerve and white matter of the brain and spinal cord.

Also Known As: Ganglioglioma, Benign; Ganglioglioma, Intracranial; Ganglioglioma, Malignant; Benign Ganglioglioma; Benign Gangliogliomas Show All >>

Networked: 191 relevant articles (3 outcomes, 20 trials/studies) for this Disease

Key Drugs and Agents for Ganglioglioma

Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
  1. Biological Tumor Markers (Tumor Markers) : 1 outcome in 1 result : IBA
  2. Iodine : 1 outcome in 1 result : IBA
  3. 2,6-dinitrotoluene (DNT) : 6 studies in 37 results : IBA
  4. DNA (Deoxyribonucleic Acid) : 3 studies in 7 results : IBA
  5. Synaptophysin : 1 study in 14 results : IBA
  6. Paraffin : 1 study in 5 results : IBA
  7. Messenger RNA (mRNA) : 1 study in 4 results : IBA
  8. Antigens : 1 study in 3 results : IBA
  9. Androgen Receptors (Androgen Receptor) : 1 study in 2 results : IBA
  10. Collagen : 1 study in 2 results : IBA
Show All >>

Diseases Related to Ganglioglioma

  1. Pinealoma (Pineoblastoma)
  2. Neoplasms (Cancer)
  3. Neuroepithelial Neoplasms (Gliomatosis Cerebri)
  4. Epilepsy (Aura)
  5. Astrocytoma (Pilocytic Astrocytoma)
Show All >>

Key Therapies for Ganglioglioma

Efficacy Chart >>
  1. Radiotherapy : 1 outcome 1 study in 18 results
  2. Brachytherapy : 1 outcome 1 study in 1 result
  3. Craniotomy : 1 study in 4 results
  4. Drug Therapy (Chemotherapy) : 8 results
  5. Ventriculoperitoneal Shunt : 3 results
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.